GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · IEX Real-Time Price · USD
0.284
-0.012 (-3.98%)
At close: Jul 19, 2024, 4:00 PM
0.285
+0.001 (0.18%)
Pre-market: Jul 22, 2024, 7:33 AM EDT
GlycoMimetics Market Cap
GlycoMimetics has a market cap or net worth of $18.33 million as of July 22, 2024. Its market cap has decreased by -82.70% in one year.
Market Cap
18.33M
Enterprise Value
-12.32M
1-Year Change
-82.70%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since January 10, 2014, GlycoMimetics's market cap has decreased from $146.90M to $18.33M, a decrease of -87.52%. That is a compound annual growth rate of -17.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 18.30M | -87.96% |
| Dec 29, 2023 | 152.00M | -4.28% |
| Dec 30, 2022 | 158.80M | 113.15% |
| Dec 31, 2021 | 74.50M | -58.57% |
| Dec 31, 2020 | 179.80M | -21.62% |
| Dec 31, 2019 | 229.40M | -43.84% |
| Dec 31, 2018 | 408.50M | -29.14% |
| Dec 29, 2017 | 576.50M | 309.74% |
| Dec 30, 2016 | 140.70M | 29.20% |
| Dec 31, 2015 | 108.90M | -19.93% |
| Dec 31, 2014 | 136.00M | -7.42% |
| Jan 10, 2014 | 146.90M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEI Pharma | 19.06M |
| Kala Pharmaceuticals | 19.04M |
| Cara Therapeutics | 18.84M |
| iBio, Inc. | 18.54M |
| Aspira Women's Health | 18.43M |
| Indaptus Therapeutics | 18.19M |
| Synlogic | 18.15M |
| Aeterna Zentaris | 17.91M |